A synthetic peptide for use as a blocking control in assays to test for specificity of EPO antibody, Alternative Names: EPO control peptide, EPO antibody Blocking Peptide, Anti-EPO Blocking Peptide, Erythropoietin Blocking Peptide, EP Blocking Peptide, MGC138142 Blocking Peptide, Erythropoietin-Alpha Blocking Peptide, EPO-a Blocking Peptide, EPO-alpha Blocking Peptide, Epoetin Blocking Peptide, EP Blocking Peptide
Aufreinigung
Prepared from rabbit serum by affinity purification via sequential chromatography on phospho- and dephospho-peptide affinity columns.
EPO
Reaktivität: Human, Affe, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
EPO
(Erythropoietin (EPO))
Substanzklasse
Hormone
Hintergrund
This gene is a member of the EPO/TPO family and encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. This protein also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types.